Back

Is lipoprotein(a) a stable measurement over time?

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Risk factors (2) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gustavo Anibal Cortez Quiroga

Hospital Alto Guadalquivir, Andújar (Spain)

6 More presentations in this session

Presentation thumbnail
Mediation role of mean blood pressure in the relationship between the changes of TyG-WHtR and incident MACE
Doctor X. Luo (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Are conventional cardiovascular risk scoring models predictive of coronary plaque progression?
Doctor C. Soh (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Ethnic differences in lipoprotein(a)-associated ASCVD risk and the impact of standard modifiable cardiovascular risk factors: insights from the multi-ethnic HELIUS cohort
Doctor M. Annink (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Performance of the PREVENT risk score for atherosclerotic cardiovascular disease in a diverse population-based cohort study: comparative assessment against the recalibrated WHO CVD risk score
Doctor A. Pedroso (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Identification of different lipid profiles in patients with zero calcium score with or without plaques after coronary computed tomography: a prospective registry to refine primary prevention
Mrs S. Alsubai (Galway, IE)
Abstract Slides

Access the full session

Session thumbnail
Risk factors (2)

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Lipoprotein(a) variability: challenging the one-time measurement paradigm in cardiovascular risk assessment
thumbnail
Congress Presentation
Is a single lipoprotein (a) measurement once in a lifetime sufficient? The results from the STAR-Lp(a) study.
thumbnail
Congress Presentation
Intraindividual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate-risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources